[1]
“A case of fatal hyperammonaemic encephalopathy in a patient with end-stage Multiple Myeloma treated with daratumumab”, Mediterr J Hematol Infect Dis, vol. 15, no. 1, p. e2023012, Jan. 2023, doi: 10.4084/MJHID.2023.012.